PerkinElmer to buy Caliper Life Sciences for $600M
Boston Business Journal by Kyle Alspach Date: Thursday, September 8, 2011, 8:07am EDT - Last Modified: Thursday, September 8, 2011, 8:14am EDT
Related: (Nasdaq: CALP) for $600 million.
Waltham, Mass.-based PerkinElmer, whose products are used by research laboratories and the life sciences industry, said it would pay cash for Hopkinton, Mass.-based Caliper, a maker of molecular imaging and detection technologies for life sciences research and diagnostics.
The $10.50-per-share acquisition price represents a 42 percent premium over Caliper's closing price Wednesday. The deal has won the unanimous support from the boards of both companies, and is expected to close in the fourth quarter, PerkinElmer said.
Robert Friel, CEO of PerkinElmer, said in a statement announcing the acquisition that it would "provide our customers with enhanced knowledge and services and a strong pipeline of innovation."
PerkinElmer said that services that would be expanded through the acquisition would include molecular, cellular, animal and tissue imaging; addition of a microfluidics platform for genomics and proteomics applications; and sample preparation technologies for key scientific workflow areas.
PerkinElmer said that Caliper CEO Kevin Hrusovsky is expected to join PerkinElmer's senior leadership team, though a position wasn't specified.
PerkinElmer has made a string of acquisitions this year, including the purchase of Canada-based Labtronics Inc., a health IT company, in May. ...
bizjournals.com |
